MEA Bioinformatics Market

MEA Bioinformatics Market Size (2023 to 2028)

The size of the Bioinformatics Market in the Middle East & Africa was worth USD 0.87 billion in 2023 and estimated to be growing at a CAGR of 15.7%, to reach USD 1.77 billion by 2028.

Bioinformatics is a field of study in which biological data is obtained by developing and using new software tools and methods. It is an interdisciplinary field of engineering, mathematics, computer science, and statistics to understand the biological information acquired. Bioinformatics comprises all the biological studies done by the use of computer programming. This field is mostly used for obtaining information on candidate genes and single nucleotide polymorphisms.

Bioinformatics is used in many areas of biology. It assists in obtaining useful information from the text and in gene ontology to organize and name data. The field of genomics and genetics assists in sequencing genomes and noting their mutations. It helps in analyzing gene and protein expression and regulation. It is useful in analyzing evolutionary aspects of molecular biology by comparing genetic and genomic data.  In experimental molecular biology, it is used in the form of techniques such as image and signal processing.

The driving factors of the Middle East and Africa Bioinformatics market are the growing need for sequencing protein and nucleic acids, rising initiatives from the government, rising help of this field in producing new medicines and clinical diagnostics, a growing number of partnerships between research organizations and companies and rising need for integrated bioinformatics systems in proteomics and genomics among others. However, a few of the restraints this market faces include high costs, lack of skilled workers, lack of user-friendly tools, and lack of interoperability among various data formats.

This research report on the MEA Bioinformatics Market has been segmented & sub-segmented into the following categories:

By Sector:

• Animal Biotechnology
• Environmental Biotechnology
  • Alternative Energy Sources
  • Waste Clean-Up/Bioremediation
  • Climate Change Studies
• Agricultural Biotechnology
  • Crop Yield Improvement
  • Pest Resistance
  • Improvement of Plant Resistance
  • Biodiversity Informatics
  • Nutritional Quality Improvement
• Forensic Biotechnology
• Medical Biotechnology
  • Drug Development
  • Clinical Diagnostics
  • Molecular Medicine
    • Personalized Medicine
    • Preventive Medicine
  • Gene Therapy
  • Reproductive Biotechnology
• Academics
• Other Sectors

By-Products and Services:

• Bioinformatics Platforms
  • Sequence Analysis Platforms
  • Sequence Alignment Platforms
  • Sequence Manipulation Platforms
  • Structural and Functional Analysis Platforms
  • Other Bioinformatics Platforms
• Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
• Bioinformatics Services
  • Data Analysis
  • Sequencing Services
  • Other Bioinformatics Services
  • Database and Management Services

By Application:

• Proteomics
• Transcriptomics
• Molecular Phylogenetics
• Chemoinformatics
• Drug Design
• Genomics

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Regionally, the market in this region is still in its nascent stages. However, factors such as the increased need for protein and nucleic acid sequencing, increasing funding for research, and technological advancements are expected to propel the growth of this market in the region.

KEY MARKET PLAYERS:

Companies such as Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc., and Waters Corporation are expected to lead the MEA bioinformatics market during the forecast period.